D'AMORE, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 2.571
AS - Asia 1.678
EU - Europa 657
AF - Africa 228
SA - Sud America 219
Continente sconosciuto - Info sul continente non disponibili 71
OC - Oceania 25
Totale 5.449
Nazione #
US - Stati Uniti d'America 2.334
VN - Vietnam 425
SG - Singapore 392
CN - Cina 274
HK - Hong Kong 167
IT - Italia 165
BR - Brasile 130
CA - Canada 98
BD - Bangladesh 86
SE - Svezia 54
GB - Regno Unito 49
FR - Francia 48
IN - India 41
DE - Germania 37
FI - Finlandia 37
PL - Polonia 35
NL - Olanda 34
AR - Argentina 23
JP - Giappone 23
ES - Italia 21
TR - Turchia 19
CI - Costa d'Avorio 18
IQ - Iraq 18
RU - Federazione Russa 18
SA - Arabia Saudita 18
PH - Filippine 17
ZA - Sudafrica 17
MX - Messico 16
ID - Indonesia 15
AT - Austria 14
HN - Honduras 14
IE - Irlanda 14
CO - Colombia 13
UZ - Uzbekistan 13
KE - Kenya 12
UG - Uganda 12
CH - Svizzera 11
JM - Giamaica 11
BJ - Benin 10
CR - Costa Rica 10
EC - Ecuador 10
LA - Repubblica Popolare Democratica del Laos 10
NI - Nicaragua 10
PK - Pakistan 10
PY - Paraguay 10
UA - Ucraina 10
AU - Australia 9
AZ - Azerbaigian 9
GN - Guinea 9
JO - Giordania 9
YE - Yemen 9
AF - Afghanistan, Repubblica islamica di 8
BF - Burkina Faso 8
DK - Danimarca 8
GE - Georgia 8
MY - Malesia 8
RS - Serbia 8
SK - Slovacchia (Repubblica Slovacca) 8
TH - Thailandia 8
VE - Venezuela 8
ZW - Zimbabwe 8
BB - Barbados 7
BZ - Belize 7
CL - Cile 7
CV - Capo Verde 7
CZ - Repubblica Ceca 7
DO - Repubblica Dominicana 7
EG - Egitto 7
GT - Guatemala 7
KZ - Kazakistan 7
TN - Tunisia 7
VC - Saint Vincent e Grenadine 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
AM - Armenia 6
AO - Angola 6
BG - Bulgaria 6
EE - Estonia 6
ET - Etiopia 6
GA - Gabon 6
GR - Grecia 6
IS - Islanda 6
KH - Cambogia 6
LB - Libano 6
LC - Santa Lucia 6
MA - Marocco 6
MG - Madagascar 6
MN - Mongolia 6
NC - Nuova Caledonia 6
PE - Perù 6
PS - Palestinian Territory 6
SI - Slovenia 6
TJ - Tagikistan 6
TZ - Tanzania 6
BY - Bielorussia 5
CU - Cuba 5
CY - Cipro 5
GP - Guadalupe 5
IL - Israele 5
LT - Lituania 5
Totale 5.187
Città #
Ashburn 370
San Jose 275
Fairfield 235
Singapore 233
Hong Kong 149
Ho Chi Minh City 133
Chandler 129
Hanoi 97
Los Angeles 93
Cambridge 91
Houston 91
Woodbridge 88
Seattle 69
Wilmington 58
Beijing 53
Council Bluffs 52
New York 45
Ann Arbor 38
Boardman 37
Da Nang 36
Padova 34
Santa Clara 28
Bytom 25
Helsinki 22
Lauterbourg 21
San Diego 20
Montreal 19
Princeton 19
Medford 18
Abidjan 17
Chicago 17
Tokyo 17
Orem 16
São Paulo 15
Toronto 15
Buffalo 13
Chennai 13
Des Moines 13
Dong Ket 13
Haiphong 13
Atlanta 12
Dublin 12
Kampala 12
London 12
Rome 12
Tashkent 12
Milan 11
Munich 11
Brooklyn 10
Dallas 10
Guangzhou 10
Hải Dương 10
Nairobi 10
Nuremberg 10
Poplar 10
Baku 9
Conakry 9
Johannesburg 9
Managua 9
Amman 8
Bến Tre 8
Cotonou 8
Naples 8
Salt Lake City 8
Vienna 8
Warsaw 8
Bridgetown 7
Harare 7
Kingston 7
Kingstown 7
Manchester 7
Ouagadougou 7
Phoenix 7
Riyadh 7
San Francisco 7
Vientiane 7
Belize City 6
Bắc Ninh 6
Cagliari 6
Castries 6
Ciudad del Este 6
Dar es Salaam 6
Dushanbe 6
Edmonton 6
Guatemala City 6
Istanbul 6
Jeddah 6
Kuala Lumpur 6
Libreville 6
New Delhi 6
Noumea 6
Phnom Penh 6
San Pedro Sula 6
Stockholm 6
Sydney 6
Turku 6
Amsterdam 5
Antananarivo 5
Boston 5
Bắc Giang 5
Totale 3.206
Nome #
Live applications of norbormide-based fluorescent probes in Drosophila melanogaster 353
A N-terminally deleted form of the CK2 alpha' catalytic subunit is sufficient to support cell viability 347
Protein kinase CK2: a potential therapeutic target for diverse human diseases 332
A journey through the cytoskeleton with protein kinase CK2 311
Dopamine–mediated immunomodulation affects choroid plexus function 292
Deciphering the role of protein kinase CK2 in the maturation/stability of F508del-CFTR 285
“Janus” efficacy of CX-5011: CK2 inhibition and methuosis induction by independent mechanisms 244
KDM2A and KDM3B as Potential Targets for the Rescue of F508del-CFTR 236
Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy - potential clinical relevance 225
Comparing the efficacy and selectivity of Ck2 inhibitors. A phosphoproteomics approach 221
How can a traffic light properly work if it is always green? The paradox of CK2 signaling 218
Analysis of the phosphoproteome of CK2α(-/-)/Δα' C2C12 myoblasts compared to the wild-type cells 209
Synthesis and Biological Characterization of a New Norbormide Derived Bodipy FL-Conjugated Fluorescent Probe for Cell Imaging 209
Impact and sustainability of antibiotic stewardship in pediatric emergency departments: Why persistence is the key to success 204
Modulation of protein kinases in the regulation of chaperone machinery leading F508-del-CFTR fate - The Proceedings of the 16th Italian Convention of Investigators in Cystic Fibrosis 196
A mutational approach to dissect the functional role of the putative CFTR “PTM-CODE” 192
Protein kinase CK2 subunits differentially perturb the adhesion and migration of GN11 cells: A model of immature migrating neurons 189
SUMOylation Inhibition Enhances Protein Transcription under CMV Promoter: A Lesson from a Study with the F508del-CFTR Mutant 188
Development of small cyclic peptides targeting the CK2α/β interface 184
Aetiology of acute respiratory infection in preschool children requiring hospitalisation in Europe-results from the PED-MERMAIDS multicentre case-control study 175
Nitrobenzoxadiazole derivatives of the rat selective toxicant norbormide as fluorescent probes for live cell imaging 170
Study of norbormide impact on plant systems 141
Editorial of special issue “protein post-translational modifications in signal transduction and diseases” 134
Regulation of the cell secretome by protein kinase CK2 modulates cell migration and extracellular matrix composition 128
null 66
Totale 5.449
Categoria #
all - tutte 15.740
article - articoli 15.382
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.122


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022253 0 0 21 24 20 38 9 19 15 22 25 60
2022/2023212 39 34 5 27 32 21 2 12 20 2 15 3
2023/2024155 10 20 19 9 17 16 9 4 7 19 10 15
2024/2025590 3 7 20 40 50 35 67 37 61 15 96 159
2025/20263.180 165 183 343 472 285 109 666 202 277 202 183 93
2026/2027345 108 177 60 0 0 0 0 0 0 0 0 0
Totale 5.449